These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 29116402)

  • 1. A critical review of the prion hypothesis of human synucleinopathies.
    Tamgüney G; Korczyn AD
    Cell Tissue Res; 2018 Jul; 373(1):213-220. PubMed ID: 29116402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Multiple System Atrophy a Prion-like Disorder?
    Jellinger KA; Wenning GK; Stefanova N
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion-like propagation of α-synuclein in neurodegenerative diseases.
    Tarutani A; Hasegawa M
    Prog Mol Biol Transl Sci; 2019; 168():323-348. PubMed ID: 31699325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy.
    Ayers JI; Lee J; Monteiro O; Woerman AL; Lazar AA; Condello C; Paras NA; Prusiner SB
    Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35115402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ɑ-Synuclein strains and the variable pathologies of synucleinopathies.
    Peelaerts W; Baekelandt V
    J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propagation of prions causing synucleinopathies in cultured cells.
    Woerman AL; Stöhr J; Aoyagi A; Rampersaud R; Krejciova Z; Watts JC; Ohyama T; Patel S; Widjaja K; Oehler A; Sanders DW; Diamond MI; Seeley WW; Middleton LT; Gentleman SM; Mordes DA; Südhof TC; Giles K; Prusiner SB
    Proc Natl Acad Sci U S A; 2015 Sep; 112(35):E4949-58. PubMed ID: 26286986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism.
    Prusiner SB; Woerman AL; Mordes DA; Watts JC; Rampersaud R; Berry DB; Patel S; Oehler A; Lowe JK; Kravitz SN; Geschwind DH; Glidden DV; Halliday GM; Middleton LT; Gentleman SM; Grinberg LT; Giles K
    Proc Natl Acad Sci U S A; 2015 Sep; 112(38):E5308-17. PubMed ID: 26324905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ɑ-Synuclein strains and seeding in Parkinson's disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences.
    Peelaerts W; Bousset L; Baekelandt V; Melki R
    Cell Tissue Res; 2018 Jul; 373(1):195-212. PubMed ID: 29704213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prion hypothesis of Parkinson's disease.
    Chu Y; Kordower JH
    Curr Neurol Neurosci Rep; 2015 May; 15(5):28. PubMed ID: 25868519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward.
    Bellomo G; De Luca CMG; Paoletti FP; Gaetani L; Moda F; Parnetti L
    Neurology; 2022 Aug; 99(5):195-205. PubMed ID: 35914941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are synucleinopathies prion-like disorders?
    Angot E; Steiner JA; Hansen C; Li JY; Brundin P
    Lancet Neurol; 2010 Nov; 9(11):1128-38. PubMed ID: 20846907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prion Properties of Alpha-Synuclein].
    Schwarzman AL; Senkevich KA; Emelyanov AK; Pchelina SN
    Mol Biol (Mosk); 2019; 53(3):380-387. PubMed ID: 31184602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial Parkinson's point mutation abolishes multiple system atrophy prion replication.
    Woerman AL; Kazmi SA; Patel S; Aoyagi A; Oehler A; Widjaja K; Mordes DA; Olson SH; Prusiner SB
    Proc Natl Acad Sci U S A; 2018 Jan; 115(2):409-414. PubMed ID: 29279394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of glia in α-synucleinopathies.
    Fellner L; Stefanova N
    Mol Neurobiol; 2013 Apr; 47(2):575-86. PubMed ID: 22941028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human α-synuclein transgenic mice.
    Lloyd GM; Sorrentino ZA; Quintin S; Gorion KM; Bell BM; Paterno G; Long B; Prokop S; Giasson BI
    Acta Neuropathol; 2022 Jun; 143(6):663-685. PubMed ID: 35488930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of Tau and α-Synuclein Pathology in the Visual System.
    Rahimi J; Milenkovic I; Kovacs GG
    J Parkinsons Dis; 2015; 5(2):333-40. PubMed ID: 25737267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prion-like Propagation of Pathological α-Synuclein in Vivo].
    Masuda-Suzukake M; Hasegawa M
    Yakugaku Zasshi; 2019; 139(7):1007-1013. PubMed ID: 31257247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.
    Goedert M; Falcon B; Clavaguera F; Tolnay M
    Curr Neurol Neurosci Rep; 2014 Nov; 14(11):495. PubMed ID: 25218483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain region-specific susceptibility of Lewy body pathology in synucleinopathies is governed by α-synuclein conformations.
    de Boni L; Watson AH; Zaccagnini L; Wallis A; Zhelcheska K; Kim N; Sanderson J; Jiang H; Martin E; Cantlon A; Rovere M; Liu L; Sylvester M; Lashley T; Dettmer U; Jaunmuktane Z; Bartels T
    Acta Neuropathol; 2022 Apr; 143(4):453-469. PubMed ID: 35141810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Sphingolipid Hydrolase Activities in Dementia with Lewy Bodies and Multiple System Atrophy.
    Usenko TS; Senkevich KA; Bezrukova AI; Baydakova GV; Basharova KS; Zhuravlev AS; Gracheva EV; Kudrevatykh AV; Miliukhina IV; Krasakov IV; Khublarova LA; Fursova IV; Zakharov DV; Timofeeva AA; Irishina YA; Palchikova EI; Zalutskaya NM; Emelyanov AK; Zakharova EY; Pchelina SN
    Mol Neurobiol; 2022 Apr; 59(4):2277-2287. PubMed ID: 35066761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.